CQRC OFFERS UP SOAR ACT AS WAY TO SUPPORT ACCESS TO NEW TECH

The Council for Quality Respiratory Care (CQRC) shared a letter with the House Energy & Commerce Health Subcommittee in advance of its hearing “Examining Policies to Enhance Seniors’ Access to Breakthrough Medical Technologies” to promote its SOAR Act. In the letter, the CQRC makes the case that the Supplemental Oxygen Access Reform (SOAR) Act (S. 1406/H.R. 2902) would:
- Support innovation by locking in the savings from Medicare’s competitive bidding program and addressing chronic underfunding for liquid oxygen
- Establish innovative strategies to eliminate fraud and abuse
- Recognize the critical importance of respiratory therapy services
“Earlier this year, more than 30 health and medical organizations sent a letter to Congress urging members to support the SOAR Act,” the letter states. “As the committee considers legislation to incentivize access to innovation in the Medicare program, we urge members to take up the SOAR Act and pass it this year.”
The CQRC is a coalition of the nation’s six leading providers and manufacturers of supplemental oxygen. Together, they provide in-home patient services and respiratory equipment to more than 600,000 of the more than 1 million Medicare patients who rely on oxygen therapy to maintain their independence and quality of life.
- Read the CQRC’s letter to the Health Subcommittee here.
- Read the letter sent to Congress by the CQRC and more than 30 health and medical organizations here.